Table V.
Patient | Gender | Age | Mutation site | Differentiation | T | N | Stage |
---|---|---|---|---|---|---|---|
1 | Female | 71 | Gly13Asp | Moderately | 3 | 0 | IIA |
2 | Female | 81 | Gly12Val | Moderately | 3 | 0 | IIA |
3 | Male | 65 | Gly12Asp | Well | 4 | 0 | IIB |
4 | Male | 72 | Gly12Ser | Moderately | 4 | 1 | IIIB |
5 | Female | 51 | Gly13Asp | Moderately | 3 | 2 | IIIC |
6 | Female | 78 | Gly12Val | Moderately | 3 | 2 | IIIC |
7 | Female | 72 | Gly12Ser | Well | 3 | 2 | IV |
8 | Male | 74 | Gly12Cys | Moderately | 3 | 1 | IV |